Franklin Resources
CORT icon

Franklin Resources’s Corcept Therapeutics CORT Stock Holding History

Franklin Resources’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Sell
212,029
-93,182
-31% -$5.63M ﹤0.01% 1040
2026
Q1 		$12.3M Sell
305,211
-162,967
-35% -$6.09M ﹤0.01% 1162
2025
Q4 		$16.3M Sell
468,178
-31,879
-6% -$2.5M ﹤0.01% 1018
2025
Q3 		$41.6M Buy
500,057
+10,717
+2% +$776K 0.01% 703
2025
Q2 		$35.9M Buy
489,340
+156,248
+47% +$11.3M 0.01% 734
2025
Q1 		$38M Buy
333,092
+59,118
+22% +$3.6M 0.01% 696
2024
Q4 		$13.8M Buy
273,974
+31,183
+13% +$1.63M ﹤0.01% 1015
2024
Q3 		$11M Buy
242,791
+2,475
+1% +$87.9K ﹤0.01% 1088
2024
Q2 		$7.81M Sell
240,316
-5,146
-2% -$141K ﹤0.01% 1158
2024
Q1 		$6.18M Buy
245,462
+17,877
+8% +$422K ﹤0.01% 1249
2023
Q4 		$7.39M Buy
227,585
+4,471
+2% +$123K ﹤0.01% 1015
2023
Q3 		$6.08M Sell
223,114
-20,704
-8% -$599K ﹤0.01% 1033
2023
Q2 		$5.42M Buy
243,818
+20,647
+9% +$475K ﹤0.01% 1089
2023
Q1 		$4.83M Sell
223,171
-15,944
-7% -$350K ﹤0.01% 1098
2022
Q4 		$4.86M Sell
239,115
-15,226
-6% -$382K ﹤0.01% 1116
2022
Q3 		$6.52M Buy
254,341
+46
+0% +$1.23K ﹤0.01% 1034
2022
Q2 		$6.05M Buy
+254,295
New +$5.54M ﹤0.01% 1066

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's CORT Position: Q2 2026 in Review

Franklin Resources reduced its Corcept Therapeutics (CORT) stake by 31% in Q2 2026, selling an estimated $5.63M and leaving 212,029 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1040.

Franklin Resources first reported a position in CORT in Q2 2022 and has held it in 17 quarters since. The position peaked at $41.6M in Q3 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Franklin Resources held 212,029 shares of Corcept Therapeutics worth $18.4M as of Q2 2026.
  • Franklin Resources sold 93,182 Corcept Therapeutics shares in Q2 2026, an estimated $5.63M.
  • Corcept Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1040 holding.
  • Franklin Resources first reported a position in Corcept Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Franklin Resources's Corcept Therapeutics position peaked at $41.6M in Q3 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.